Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S J C M M Neggers

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|April 19, 2011
Combination treatment with somatostatin analogues and pegvisomant in acromegalyS J C M M Neggers, A J van der Lely
Handbook of Clinical Neurology|September 25, 2014
Medical approach to pituitary tumorsS J C M M Neggers, A J van der Lely
The Netherlands Journal of Medicine|October 20, 2015
Review of current and emerging treatment options in acromegalyA Muhammad, A J van der Lely, S J C M M Neggers
Clinical Endocrinology|January 25, 2012
What is active acromegaly and which parameters do we have?S J C M M Neggers, N R Biermasz, A J van der Lely
Endocrine|December 15, 2015
Combined treatment of somatostatin analogues with pegvisomant in acromegalyS E Franck, A Muhammad, A J van der Lely, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 24, 2009
Components of the metabolic syndrome in 500 adult long-term survivors of childhood cancerM van Waas, S J C M M Neggers, R Pieters, et al.
Critical Reviews in Oncology/Hematology|January 22, 2019
Metabolic syndrome as cardiovascular risk factor in childhood cancer survivorsV G Pluimakers, M van Waas, S J C M M Neggers, et al.
European Journal of Endocrinology|August 6, 2015
Pegvisomant in combination with long-acting somatostatin analogues in acromegaly: the role of the GH receptor deletion of exon 3S E Franck, A J van der Lely, P J D Delhanty, et al.
Clinical Endocrinology|October 5, 2017
Disagreement in normative IGF-I levels may lead to different clinical interpretations and GH dose adjustments in GH deficiencyA J Varewijck, A J van der Lely, S J C M M Neggers, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 4, 2011
Endocrine late sequelae in long-term survivors of childhood non-Hodgkin lymphomaM van Waas, S J C M M Neggers, M L Te Winkel, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|April 19, 2011
Combination treatment with somatostatin analogues and pegvisomant in acromegalyS J C M M Neggers, A J van der Lely
Handbook of Clinical Neurology|September 25, 2014
Medical approach to pituitary tumorsS J C M M Neggers, A J van der Lely
The Netherlands Journal of Medicine|October 20, 2015
Review of current and emerging treatment options in acromegalyA Muhammad, A J van der Lely, S J C M M Neggers
Clinical Endocrinology|January 25, 2012
What is active acromegaly and which parameters do we have?S J C M M Neggers, N R Biermasz, A J van der Lely
Endocrine|December 15, 2015
Combined treatment of somatostatin analogues with pegvisomant in acromegalyS E Franck, A Muhammad, A J van der Lely, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 24, 2009
Components of the metabolic syndrome in 500 adult long-term survivors of childhood cancerM van Waas, S J C M M Neggers, R Pieters, et al.
Critical Reviews in Oncology/Hematology|January 22, 2019
Metabolic syndrome as cardiovascular risk factor in childhood cancer survivorsV G Pluimakers, M van Waas, S J C M M Neggers, et al.
European Journal of Endocrinology|August 6, 2015
Pegvisomant in combination with long-acting somatostatin analogues in acromegaly: the role of the GH receptor deletion of exon 3S E Franck, A J van der Lely, P J D Delhanty, et al.
Clinical Endocrinology|October 5, 2017
Disagreement in normative IGF-I levels may lead to different clinical interpretations and GH dose adjustments in GH deficiencyA J Varewijck, A J van der Lely, S J C M M Neggers, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 4, 2011
Endocrine late sequelae in long-term survivors of childhood non-Hodgkin lymphomaM van Waas, S J C M M Neggers, M L Te Winkel, et al.
Pageof 4